Back to mobile site

Form SCHEDULE 13G Protalix BioTherapeutics Filed by: HOLD Alapkezelo Zrt.

October 15, 2026 8:49 AM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  Hungarian investment fund management company.


SCHEDULE 13G



 
HOLD Alapkezelo Zrt.
 
Signature:David Pekar
Name/Title:Chief Investment Officer
Date:10/15/2026


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G